Inventor · disambiguated record
Neil James Gallagher
Also filed as: GALLAGHER NEIL · GALLAGHER NEIL J · GALLAGHER NEIL JAMES
6 granted patents·6 pending applications·132 citations·filing 2003–2010
84Inventor score
Files withASTEX THERAPEUTICS LTD3GALLAGHER NEIL JAMES3ASTRAZENECA AB2BERDINI VALERIO1BOYLE FRANCIS T1
Top patents by PatentIndex Score
12 records- 0194US8399442B2Pharmaceutical compoundsBERDINI VALERIO·Filed 2006·Granted Mar 19, 2013·62 cites·26 claims
- 0293US8277807B2Pharmaceutical combinationsGALLAGHER NEIL JAMES·Filed 2007·Granted Oct 2, 2012·39 cites·20 claims
- 0386US8435970B2Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-ureaCURRY JAYNE ELIZABETH·Filed 2007·Granted May 7, 2013·8 cites·24 claims
- 0478US9061029B2Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activityGALLAGHER NEIL·Filed 2010·Granted Jun 23, 2015·18 cites·8 claims
- 0575US8916552B2Pharmaceutical combinationsGALLAGHER NEIL JAMES·Filed 2007·Granted Dec 23, 2014·3 cites·4 claims
- 0672US8883790B2Pharmaceutical combinationsGALLAGHER NEIL JAMES·Filed 2007·Granted Nov 11, 2014·2 cites·8 claims
- 0753US2010021420A1Combinations of pyrazole derivatives for the inhibition of cdks and gsk'sASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 0852US2010004181A1Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl) pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonateASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0951US2006287241A1Combination comprising N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonateASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1045US2011159111A1Pharmaceutical combinationsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 1142US2009263398A1Pharmaceutical combinationsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 1230US2006122180A1Therapeutic treatmentBOYLE FRANCIS T·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →